PetIQ, Inc. (PETQ)
USD 30.98
(-0.03%)
USD 30.98
(-0.03%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 437.82 Million USD | -4.11% |
| 2022 | 456.58 Million USD | -1.98% |
| 2021 | 465.8 Million USD | 24.19% |
| 2020 | 375.07 Million USD | 38.26% |
| 2019 | 271.28 Million USD | 147.22% |
| 2018 | 109.73 Million USD | 524.5% |
| 2017 | 17.57 Million USD | -31.34% |
| 2016 | 25.59 Million USD | -21.13% |
| 2015 | 32.44 Million USD | 117.41% |
| 2014 | 14.92 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 436.01 Million USD | -0.09% |
| 2024 Q1 | 436.42 Million USD | -0.32% |
| 2023 Q4 | 437.82 Million USD | -2.41% |
| 2023 Q1 | 453.59 Million USD | -0.66% |
| 2023 Q2 | 451.37 Million USD | -0.49% |
| 2023 Q3 | 448.61 Million USD | -0.61% |
| 2023 FY | 437.82 Million USD | -4.11% |
| 2022 Q4 | 456.58 Million USD | -0.76% |
| 2022 FY | 456.58 Million USD | -1.98% |
| 2022 Q1 | 489.4 Million USD | 5.07% |
| 2022 Q2 | 467.99 Million USD | -4.38% |
| 2022 Q3 | 460.08 Million USD | -1.69% |
| 2021 FY | 465.8 Million USD | 24.19% |
| 2021 Q3 | 456.64 Million USD | -3.41% |
| 2021 Q4 | 465.8 Million USD | 2.01% |
| 2021 Q2 | 472.73 Million USD | 2.35% |
| 2021 Q1 | 461.88 Million USD | 23.14% |
| 2020 Q1 | 344.94 Million USD | 27.15% |
| 2020 Q4 | 375.07 Million USD | 0.26% |
| 2020 Q3 | 374.08 Million USD | -0.56% |
| 2020 Q2 | 376.18 Million USD | 9.06% |
| 2020 FY | 375.07 Million USD | 38.26% |
| 2019 Q4 | 271.28 Million USD | -1.06% |
| 2019 FY | 271.28 Million USD | 147.22% |
| 2019 Q1 | 124.38 Million USD | 13.35% |
| 2019 Q2 | 110.38 Million USD | -11.26% |
| 2019 Q3 | 274.18 Million USD | 148.39% |
| 2018 Q4 | 109.73 Million USD | -5.54% |
| 2018 FY | 109.73 Million USD | 524.5% |
| 2018 Q1 | 138.54 Million USD | 688.45% |
| 2018 Q2 | 116.55 Million USD | -15.88% |
| 2018 Q3 | 116.16 Million USD | -0.33% |
| 2017 Q3 | 20.33 Million USD | -39.18% |
| 2017 Q2 | 33.43 Million USD | -22.98% |
| 2017 Q1 | 43.4 Million USD | 69.59% |
| 2017 FY | 17.57 Million USD | -31.34% |
| 2017 Q4 | 17.57 Million USD | -13.57% |
| 2016 FY | 25.59 Million USD | -21.13% |
| 2016 Q4 | 25.59 Million USD | 0.0% |
| 2016 Q1 | 26.13 Million USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | 32.44 Million USD | 117.41% |
| 2014 FY | 14.92 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | -41.383% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | -380.719% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 10.642% |
| Cosmos Health Inc. | 3.03 Million USD | -14324.08% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -1947151.379% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | 12.706% |
| Cronos Group Inc. | 1.55 Million USD | -27983.387% |
| Incannex Healthcare Limited | 210 Thousand USD | -208385.714% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | -1180.55% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | -263.306% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -81122.926% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -81122.926% |
| SCYNEXIS, Inc. | 12.15 Million USD | -3500.79% |
| Safety Shot Inc | 304.9 Thousand USD | -143491.325% |
| Theratechnologies Inc. | 51.26 Million USD | -754.1% |
| Alpha Teknova, Inc. | 13.25 Million USD | -3204.053% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 14.787% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -503141.379% |
| Dynavax Technologies Corporation | 252.41 Million USD | -73.45% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 12.139% |
| Radius Health, Inc. | 339.66 Million USD | -28.898% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -373692.997% |
| Alvotech | 1.02 Billion USD | 57.401% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | -3185.457% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -130207.062% |
| Shineco, Inc. | 10.01 Million USD | -4270.625% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Journey Medical Corporation | 14.62 Million USD | -2894.255% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | -6284.669% |
| Embecta Corp. | 1.62 Billion USD | 73.064% |
| Harrow Health, Inc. | 183.17 Million USD | -139.021% |
| Procaps Group, S.A. | 28.41 Million USD | -1441.077% |
| Biofrontera Inc. | 804 Thousand USD | -54355.224% |
| DURECT Corporation | 2.7 Million USD | -16103.553% |
| PainReform Ltd. | 30 Thousand USD | -1459300.0% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | -1218.894% |
| OptiNose, Inc. | 611 Thousand USD | -71556.301% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -96124.176% |
| Organogenesis Holdings Inc. | 60.74 Million USD | -620.751% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -3324.711% |
| ProPhase Labs, Inc. | 10.25 Million USD | -4168.083% |
| Phibro Animal Health Corporation | 458.28 Million USD | 4.466% |
| Procaps Group S.A. | 28.41 Million USD | -1441.077% |
| TherapeuticsMD, Inc. | 6.53 Million USD | -6602.694% |
| Viatris Inc. | 16.18 Billion USD | 97.295% |
| Rockwell Medical, Inc. | 8.29 Million USD | -5179.393% |
| Aytu BioPharma, Inc. | 10.87 Million USD | -3925.191% |
| Tilray Brands, Inc. | 287.93 Million USD | -52.055% |
| Talphera, Inc. | - USD | -Infinity% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | -69.501% |
| Alimera Sciences, Inc. | 64.48 Million USD | -578.906% |
| Assertio Holdings, Inc. | 38.51 Million USD | -1036.781% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -323997.447% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | -1236.447% |
| Hempacco Co., Inc. | 5.93 Million USD | -7281.891% |
| Alvotech | 1.02 Billion USD | 57.401% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 28.94% |
| Kamada Ltd. | 7.43 Million USD | -5786.26% |
| Currenc Group, Inc. | 2.5 Million USD | -17364.082% |
| Indivior PLC | 235.66 Million USD | -85.779% |
| Evoke Pharma, Inc. | 5 Million USD | -8656.4% |
| Flora Growth Corp. | 942 Thousand USD | -46377.707% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -1947151.379% |
| Evolus, Inc. | 120.35 Million USD | -263.762% |
| HUTCHMED (China) Limited | 48.18 Million USD | -808.548% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 25.692% |
| Akanda Corp. | 2.49 Million USD | -17432.752% |